Asko-Seljavaara S - Search Results

1

DNA aneuploidy and low S-phase fraction as favourable prognostic signs in metastatic melanoma.

Muhonen T, Pyrhönen S, Laasonen A, Asko-Seljavaara S, Franssila K. Muhonen T, et al. Br J Cancer. 1991 Oct;64(4):749-52. doi: 10.1038/bjc.1991.392. Br J Cancer. 1991. PMID: 1911224 Free PMC article.

2

Prognostic value of tumour vascularity in primary melanoma.

Ilmonen S, Kariniemi AL, Vlaykova T, Muhonen T, Pyrhönen S, Asko-Seljavaara S. Ilmonen S, et al. Melanoma Res. 1999 Jun;9(3):273-8. doi: 10.1097/00008390-199906000-00009. Melanoma Res. 1999. PMID: 10465583

3

Prognosis of primary melanoma.

Ilmonen S, Asko-Seljavaara S, Kariniemi AL, Jeskanen L, Pyrhönen S, Muhonen T. Ilmonen S, et al. Scand J Surg. 2002;91(2):166-71. doi: 10.1177/145749690209100206. Scand J Surg. 2002. PMID: 12164517

4

Tumour growth rate and DNA flow cytometry parameters as prognostic factors in metastatic melanoma.

Muhonen T, Pyrhönen S, Laasonen A, Wasenius VM, Asko-Seljavaara S, Franssila K, Kangas L. Muhonen T, et al. Br J Cancer. 1992 Sep;66(3):528-32. doi: 10.1038/bjc.1992.307. Br J Cancer. 1992. PMID: 1520590 Free PMC article.

5

DNA ploidy pattern and S-phase characteristics of metastatic melanoma.

Muhonen T, Pyrhönen S, Laasonen A, Asko-Seljavaara S, Franssila K. Muhonen T, et al. Virchows Arch B Cell Pathol Incl Mol Pathol. 1991;60(4):253-7. doi: 10.1007/BF02899554. Virchows Arch B Cell Pathol Incl Mol Pathol. 1991. PMID: 1681614

6

Mouse subrenal capsule assay chemosensitivity and DNA flow cytometry parameters of human melanoma metastases.

Muhonen T, Pyrhönen S, Laasonen A, Wasenius VM, Asko-Seljavaara S, Franssila K, Kangas L. Muhonen T, et al. Acta Oncol. 1994;33(4):431-7. doi: 10.3109/02841869409098440. Acta Oncol. 1994. PMID: 8018377

7

Ki-67, Bcl-2 and p53 expression in primary and metastatic melanoma.

Ilmonen S, Hernberg M, Pyrhönen S, Tarkkanen J, Asko-Seljavaara S. Ilmonen S, et al. Melanoma Res. 2005 Oct;15(5):375-81. doi: 10.1097/00008390-200510000-00005. Melanoma Res. 2005. PMID: 16179864

8

Tenascin-C in primary malignant melanoma of the skin.

Ilmonen S, Jahkola T, Turunen JP, Muhonen T, Asko-Seljavaara S. Ilmonen S, et al. Histopathology. 2004 Oct;45(4):405-11. doi: 10.1111/j.1365-2559.2004.01976.x. Histopathology. 2004. PMID: 15469480

9

Anti-melanoma antibodies bind preferentially to diploid metastases in immunoscintigraphy.

Pyrhönen S, Liewendahl K, Muhonen T, Laasonen A, Asko-Seljavaara S, Lindroth L, Franssila KO, Virkkunen P, Brownell AL. Pyrhönen S, et al. Nucl Med Commun. 1990 Sep;11(9):597-605. doi: 10.1097/00006231-199009000-00003. Nucl Med Commun. 1990. PMID: 2234695

10

Response of subcutaneous and cutaneous metastases of malignant melanoma to combined cytostatic plus interferon therapy.

Hahka-Kemppinen M, Muhonen T, Virolainen M, Jekunen A, Asko-Seljavaara S, Pyrhönen S. Hahka-Kemppinen M, et al. Br J Dermatol. 1995 Jun;132(6):973-7. doi: 10.1111/j.1365-2133.1995.tb16958.x. Br J Dermatol. 1995. PMID: 7544996

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters